Pneumococcal polysaccharide conjugate vaccine (adsorbed, GlaxoSmithKline)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePneumococcal polysaccharide conjugate vaccine (adsorbed, GlaxoSmithKline)
Drug Alias Name10-valent pneumococcal vaccine conjugate่‚บ็‚ŽๅŒ็ƒ่Œ่žๅˆ็–ซ่‹—๏ผˆ่‘›ๅ…ฐ็ด ๅฒๅ…‹๏ผ‰Pneumococcal 10-valent conjugate vaccine10-valent pneumococcal conjugate vaccineSynflorix +[9]ย 
ClassificationVaccines > Development/production technology > Conjugated vaccineVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPneumococcal InfectionsStreptococcal Infections
Global Approved IndicationsPneumococcal Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2009/03/29
Country/TerritoryPanamaSlovakiaSweden +[8]ย 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Biologicals SA
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsPneumococcal Infections
Inactive IndicationsStreptococcal Infections

Other Information

ATC CodeJ07AL52
Related LinksWikipediaKEGG